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Objective: The purpose of this study was to provide detailed information as to the
modiﬁcation of electrophysiological properties of pulmonary veins (PVs) and adjacent left
atrial (LA) tissue caused by circumferential ablation (ABL) of superior and inferior
pulmonary vein ostia using a novel radio-frequency balloon catheter (RBC), and to correlate
such changes with recurrence or non-recurrence of atrial ﬁbrillation (AF).
Background: Although isolation of the triggering foci in PVs using conventional ABL
techniques is useful in the treatment of AF, ABL of PVs per se is time consuming and tends to
be associated with high AF recurrence rate.
Methods and Results: Forty-nine patients with AF refractory to antiarrhythmic medication
underwent circumferential ablation of PV-LA junction by RBC. Post ablation changes in
electrophysiological properties around the PV ostia were studied with a basket catheter and
were correlated with AF recurrence in 34 (1st study) early cases (ablating 68 superior PVs)
and 15 (2nd study) later cases (53 superior and inferior PVs). Total elimination of PV
potentials or PV-LA dissociation was achieved in 93% (63/68 PVs) and 93% (49/53 PVs),
respectively. During mean follow-up periods of 24:1 4:1 and 13:3 1:7 months, AF
recurred in 38% (13/34 cases) and 13% (2/15) in early and later groups, respectively, but no
case developed severe PV stenosis. Although the amplitude of PV and periostial LA potentials
were decreased (p < 0:0001) in all patients, the remaining PV potentials in 34 non-recurrence
cases were deﬁnitely smaller than those in 15 recurrence cases (p < 0:0001). When a cut-oﬀ
level of less than 0.4mV in receiver operating characteristic curves was used, its negative
predictive value for non-recurrence of AF was 93% and speciﬁcity was 95%.
Conclusions: Circumferential ablation around the PV ostia using the RBC is eﬀective in the
treatment of AF even in a single session, and AF recurrence may well be predicted by
precisely measuring the amplitude of remaining PV-LA potentials.
(J Arrhythmia 2005; 21: 384–397)
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Introduction
Electrical disconnection between pulmonary veins
(PVs) and the left atrium (LA) by catheter ablation
of either the pulmonary veins per se or adjacent LA
tissue is now a frequently used therapeutic approach
in the treatment of paroxysmal atrial ﬁbrillation
(AF).1–3) However, a high recurrence rate (44%)2)
and frequent complication of PV stenosis have been
reported.4,5) It is quite possible that localization of
the foci responsible for AF recurrence at more
proximal sites around the PV ostia is a major cause
of such a poor performance of conventional ablative
techniques.2) Furthermore, variations of PV anatomy
including funnel shaped ostium and early branching
are not uncommon, making successful ablation of all
the foci diﬃcult.6,16)
In contrast, surgical isolation of PVs and posterior
LA wall around the PV ostium (LA MAZE,
RADIAL approach) has yielded better clinical
results in patients with paroxysmal or persistent AF
and even in many cases of chronic AF.7,8) These
reports suggested that tissues around the PV ostia
could play an important role in initiating and
perpetuating AF.
Based on such considerations, we developed a
novel radiofrequency thermal balloon catheter
(RBC), whose unique balloon shape snugly ﬁts
around the PV ostium and enables us to circum-
ferentially ablate the entire ostial region.9,16) Al-
though the results of our preliminary study ablating
the ostium of both the right and left superior PVs
were quite promising, recurrence of AF has still been
observed in certain cases.16) Since localization of the
responsible foci within or around the inferior PVs is
suspected as a possible cause of such failures,
circumferential ablation of all four PV ostia would
then be the next logical step. Hence, it is considered
desirable to (1) precisely identify the changes in the
electrophysiological properties of the PVs and
adjacent LA tissue produced by circumferential
ostial ablation, and (2) correlate those ﬁndings with
success or failure of maintaining sinus rhythm. The
present study has been designed to precisely analyze
those data in a hope that such information would
help us delineate a more eﬀective ablative strategy in
the treatment of paroxysmal as well as chronic AF.
Methods
1) Patient Characteristics
The study population consisted of 49 consecutive
patients (44 male, 58 10 years old) who were
markedly symptomatic with multi-drug-resistant
paroxysmal AF. Warfarin was administered to all
patients for more than 4 weeks to maintain their
international normalized ratios (INR) between 1.5
and 2.5. Eighteen patients had hypertension and 8
had diabetes mellitus. Three dimensional electron
beam computed tomography was performed to
measure the diameter of each PV ostium, and
trans-esophageal echocardiography was carried out
to elucidate LA anatomy. Patients with intraatrial
thrombi or structural heart disease were excluded
Injection&Mixing System
RF Generator
A unipolar electrode filament
Radio frequency Thermal monitoring
system
The electric plate
Central Rumen
Figure 1 Schema of the novel radiofrequency thermal balloon (RBC) system.
Right panel shows this RBC catheter wedged at the LA-PV junction area, and schematic 3-dimensional view of broad ablation at
the junction.
LA: left atrium, LSPV: left superior pulmonary vein, RSPV: right superior pulmonary vein, LIPV: left inferior pulmonary vein,
RIPV: right inferior pulmonary vein, FO: foramen ovale.
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from the study. All enrolled patients signed an
informed consent form approved by the hospital
ethics committee.
2) New Device System
As has been described previously, this original
RBC (Toray Industries, Inc., Tokyo)10) is mechan-
ically similar to the one for coronary angioplasty
(SST balloon catheter, Japan Crescent). The instru-
ment is composed of an 11F outer shaft, a 4F inner
tube and a balloon at the tip. The inner tube can be
slid into the main shaft. A 0.035-in. guide wire is
inserted into the central lumen of the inner tube
through which a contrast medium can be injected. In
the space between the inner tube and the outer shaft,
there are Teﬂon-coated leads, which are connected to
the thermal monitoring system and the RF current
generator, and a tube with a turn-cock used to dilate
the balloon with ﬂuid. The tip is equipped with an
onion-shaped, semi-compliant balloon with an in-
ﬂated diameter of either 20, 25 or 30mm, which is
ﬁxed between the distal end of the outer shaft and
that of the inner tube (Figure 1). The balloon
membrane, the shaft and the tube are made of
heat-proof, antithrombotic resin. A unipolar elec-
trode ﬁlament is coiled around the inner tube inside
the balloon to deliver RF energy, along which a
thermocouple sensor is mounted to monitor the
intraballoon temperature during energy delivery.
3) Electrophysiological Studies Prior to Ablation
In each patient, clinical electrophysiological stud-
ies were carried out under antiarrhythmic medication
previously ineﬀective. A decapolar catheter was
inserted in the coronary sinus from the right internal
cervical vein. Two quadripolar catheters were
positioned in high right atrium and close to the His
bundle, respectively, via the left femoral vein. In
addition, a 16-F soft-tipped sheath was positioned in
LA via transseptal approach under intracardiac
echocardiograpy (ICE) guidance (EP Technologies,
Mountain View, CA, USA). After conﬁrmation of
the PV-LA anatomy by selective venography using a
guidewire and a custom made catheter (5-F, Mediﬁcs
Japan, Tokyo) or a 8.5-F sheath for the basket
catheter (Boston Scientiﬁc, USA) (Figure 2A, 3-IA,
3-IIA), the most proximal electrode of the basket
catheter (31mm) was positioned at the LA-PV
junction (Figure 2B, 3-IB, 3-IIB). Bipolar intra-
cardiac electrograms were recorded at a ﬁlter setting
of 30–500Hz by use of a computerized mapping
system (Prucka Cardio Lab: GE Marquette), simul-
taneously with body surface electrocardiogram
(ECG). Endocardial stimulation was achieved with
a stimulus intensity of twice to three times the
diastolic threshold. For the left superior PV (LSPV),
constant burst pacing and the application of prema-
ture stimuli were performed from coronary sinus
(CS) distally. For the right superior PV (RSPV),
pacing in a similar manner was carried out from the
right atrial appendage (RAA). If AF was provoked,
cardioversion was attempted at least twice. Subse-
quent ablation was made even in those cases where
cardioversion was unsuccessful. Heparin was titrated
to maintain an activation coagulation time (ACT) of
250 to 350 seconds. After the electrophysiological
study, the basket catheter was replaced by an RBC
whose balloon diameter was 5–10mm larger than
that of the PV ostium as determined by selective
venography. Those patients with PV ostium diame-
ters smaller than 12mm were excluded from the
study to avoid the complication of PV stenosis.
4) Ablation procedure
After the initial clinical electrophysiological stud-
ies, the balloon was wedged at the LA-PV junction.
Proper positioning of the balloon was ﬂuoroscopi-
cally conﬁrmed by demonstrating that the contrast
medium injected into the PV through the central
lumen of the inner tube did not leak into the LA.
Once such an optimal positioning of the balloon was
conﬁrmed (Figure 2C, 3-IC, 3-IIC), RF current at
13.56MHz (Medix Generator, Nihon Medix Co.,
Ltd., Chiba, Japan) was delivered for 3–4min (early
cases) or 4–5min (later cases) between the coil
electrode inside the balloon and the electric plate
positioned on the body surface. Intra-balloon tem-
perature was constantly monitored and maintained at
60–67 C (early cases) or 67–75 C (later cases) by
regulating the output of RF energy (200W). In
addition, blood was continuously suctioned from the
central lumen of the catheter at a rate of 10ml/min
(early cases) or 5% glucose was infused at a rate of
10–15ml/min (later cases) using an infusion pump
during energy delivery to avoid overheating of the
blood in the PV. Because the diﬀerence between the
temperature of the tissue contacting the balloon
membrane and that at the thermal sensor during
energy delivery measured 10 to 15 C in in-vitro
studies (unpublished observation), the tissue temper-
ature would have reached 50 to 65 C during
ablation. Also it was able to maintain the balloon
temperature uniformly by using the agitation system
(Figure 1).
5) Electrophysiological Studies After Ablation
Recording of electrograms from the PV and its
ostial region was repeated following the RF energy
delivery. As sometimes PV potential and LA
potentials were confusing even with CS distal or
RAA pacing, we deﬁned max voltage as LA-PV
junctional potentials before ablation. We stopped the
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procedure even though slight PV potentials remained
if PV potential elimination or dissociation could not
be achieved despite repeated attempts to a maximum
of 6 ablations. All procedures for were completed
when we could calibrate each maximum PV and
adjacent LA potential.
Annihilation was classiﬁed as PV potentials or PV
and adjacent LA potentials being eliminated com-
pletely on all splines of the basket catheter (Fig-
ures 2, 3), whereas persistence of PV potential even
in only one spline was designated as partial
elimination (Figure 4).
6) End point
Immediately after the procedure, the RBC was
Figure 2
I: Complete elimination of PV po-
tentials (LSPV). After the ﬁrst abla-
tion, LA-PV interval was prolonged
and in the fourth session all PV
potentials disappeared completely
with signiﬁcant reduction of LA
potentials (far ﬁeld potentials). A:
PV venogram, B: Basket catheter
positioned at the LA-PV junction. C:
25mm balloon was located at the
junction.
II: Complete elimination of PV and
LA potentials (Annihilation) (LIPV).
Note that all PV potentials and al-
most all LA potentials at the junction
have disappeared after ablation. This
case maintained sinus rhythm during
the follow-up period. C: A 20mm
balloon was set at the junction with a
wedge venogram showing no leaks
from PV to LA. ABL: ablation.
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replaced by the basket catheter and the position was
ﬁxed as close as possible to that of the pre-ablation
study, so that amplitudes of the PV and adjacent LA
potentials could be compared between pre- and post-
ablation records. When either (1) annihilation of PV
potentials or both PV and LA potentials or (2) LA-
PV dissociation was conﬁrmed, the procedure was
considered successful. Also we stopped the proce-
dure even if slight PV potentials remained after a
maximum 6 procedures in each PV.
7) Follow-up
After the procedure, the patients were placed on
anticoagulant therapy and their cardiac rhythm was
studied by Holter ECG for 48 hours. Holter ECG
records were repeatedly obtained at 4 to 6 weeks and
12 weeks following ablation. Antiarrhythmic medi-
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Figure 3
I: Complete elimination of PV and
LA potentials (Annihilation) (Com-
mon oriﬁce of RSPV and RIPV). The
left upper panel shows right PV with
common oriﬁce and LA-PV junc-
tional potentials on the basket cath-
eter during atrial ﬁbrillation before
ablation. The panel immediately to
the right shows complete elimination
of all potentials after ablation. A:
Angiography of the right PV indi-
cated a common oriﬁce of right
superior and inferior PVs. Also note
that the anatomical junction between
LA and PV was clearly revealed by
angiography. B: The basket catheter
positioned at the junction between
LA and right PV to record the
potentials at the oriﬁce area. Note
that clear PV potentials could be
detected even in the common oriﬁce
area. Abbreviations are the same as
in Figure 2. C: A 30mm balloon was
positioned at the common oriﬁce of
right PV whose diameter was 26mm,
and dilated to maximal size of 34mm
(Max power 140W, the temperature
inside the balloon was 75 C and
ablated two times for a total of
8min).
II: Complete elimination of PV and
LA potentials (Annihilation) (RIPV).
Note that all potentials including LA
potentials at the junction have dis-
appeared after ablation. This case
also maintained sinus rhythm during
the follow-up period. C: A 20mm
balloon was set at the junction with
wedge venogram showing no leaks
from PV to LA. ABL: ablation.
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cation was withdrawn when a patient had no
recurrence of AF for 4 to 8 weeks. Contrariwise,
those patients who noted the recurrence of symptoms
were asked to report the duration and frequency of
AF episodes. In addition, all patients underwent 3-
dimensional CT of LA and PVs at one, three and six
months after ablation.
8) Statistical Analyses
Continuous variables were compared by means of
2-tailed Student’s t test, whereas 2 or Fisher’s exact
test was used for discrete variables. When the p
value was less than 0.05, the diﬀerence was
considered statistically signiﬁcant. Then, the rela-
tionship between the amplitude of post-ablation PV
potentials and late AF recurrence was assessed. The
log-rank test was used to compare Kaplan–Meier
survival curves in the two (early and later) groups.
Receiver operating characteristic curves were used
to derive cut-oﬀ values for the post-ablation PV
potential amplitude that can predict recurrence or
non-recurrence.
Results
1) Analysis of Early Cases
In the 34 early cases in which a total of 68
superior PVs were ablated, either annihilation (com-
plete elimination of all PV potentials) or electrical
dissociation between LA and PVs was achieved in
41% (28 PVs), whereas partial elimination was seen
in 56% (38 PVs). During the follow-up periods
averaging 14:1 4:1 months, normal sinus rhythm
was maintained in 21 cases (62%), whereas AF
recurred in 13 (38%). When details of the ablation
procedure were compared between the groups with
and without AF recurrence (Table 1), no signiﬁcant
diﬀerences were noted with regard to the duration of
AF prior to ablation, total procedure times as well as
total ﬂuoroscopic time.
Contrariwise, total ablation time for LSPV was
longer and number of RF energy delivery for LSPV
was greater in the non-recurrence group than in the
recurrence group. These values were not signiﬁcant-
ly diﬀerent between the two groups with reference to
RSPVs. It was also evident that a majority of patients
in the recurrence group (22=26 ¼ 85%) showed only
partial elimination of PV potentials. With reference
to the non-recurrence group, on the other hand,
complete elimination or LA-PV dissociation was
noted in 24 of 40 PVs (60.0%) when the two cases
developing atrial ﬂutter during the procedure were
excluded. Table 2 compares post-ablation electro-
physiological properties between patients with and
without AF recurrence in the early cases. It was
found that, for both LSPVs and RSPVs, the
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Figure 4 Example of partial Elimination.
The left panel: A discrete PV potential (0.3mV) in only a solitary C12–34 splint was recognized. This case
maintained sinus rhythm during the follow-up period. The right panel: In contrast, a discrete PV potential
was recognized in three splints. Note that this potential remained at proximal site of the LA-PV junction. In
addition, the amplitude was relatively high (0.8mV). This was a case involving recurrence.
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amplitude of remaining PV and periostial LA
potentials was signiﬁcantly smaller in the non-
recurrence group.
2) Comparison of Early and Later Cases
Based on the aforementioned observations in early
cases, we proceeded to carry out more complete
ablation of PV and periostial regions of all four PVs
in later cases. Thus, the number of RF energy
deliveries to both LSPV and RSPV was increased by
an average of 60% and total ablation time was
almost doubled (Table 3). This caused a marked
increase in the percentage of complete elimination to
85% (45 PVs), and decrease in the percentage of
partial elimination to 7.5% (4 PVs). Except for the
Table 1 Comparison of ablation procedure between patients with and without AF recurrence case (Early
cases).
Recurrence group Non-recurrence group p
Number of cases 13 (38.2%) 21 (61.8%)
Number of Pvs 26 42
Follow up period (M) 14:4 3:5 14:0 4:6 ns
Duration of AF 6:9 6:2 6:1 4:0 ns
Complete elimination (PV) 4 19 p ¼ 0:003#
Partial elimination (PV) 22 16
PV-LA dissociation (PV) 0 5
AFL (PV) 0 2
Total procedure time (min) 135 30 (98–190) 144 30 (110–220) ns
Total ﬂuoroscopic time (min) 40 10 (28–59) 32 14 (21–72) ns
Total ABL Time/PV
LSPV (min) 4:5 2:0 9:2 4:3 p ¼ 0:0008
RSPV (min) 4:0 1:6 5:6 2:7 p ¼ 0:062
No of RF delivery
LSPV 1:6 0:87 2:6 1:1 p ¼ 0:011
RSPV 1:3 0:48 1:7 0:78 p ¼ 0:100
# Fisher’s exact test
Follow up period is based upon the period of analysis of early cases before late study
Table 2 Comparison of post-ablation electrophysiological properties between patients with and without
AF recurrence case (Early cases).
Recurrence group
N ¼ 13
Non-recurrence group
N ¼ 21 p
LSPV
Complete elimination (PV) 2 10 p ¼ 0:024#
Partial elimination (PV) 11 9
PV-LA dissociation (PV) 0 2
AFL (PV) 0 1
Amplitude of remaining potentials
PV (mV) 1:18 0:92 0:55 0:45 p ¼ 0:013
LA (mV) 0:23 0:12 0:14 0:10 p ¼ 0:017
RSPV
Complete elimination (PV) 2 9 p ¼ 0:034#
Partial elimination (PV) 10 8
PV-LA dissociation (PV) 0 3
AFL (PV) 0 1
Amplitude of remaining potentials
PV (mV) 1:11 0:41 0:45 0:45 p ¼ 0:0002
LA (mV) 0:20 0:10 0:12 0:11 p ¼ 0:031
# Fisher’s exact test
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two patients who developed atrial ﬂutter during the
procedure, post-ablation PV potentials were signiﬁ-
cantly smaller than pre-ablation in individual PVs
(LSPV: p < 0:0001; RSPV: p < 0:0001; LIPV:
p < 0:0001; RIPV: p ¼ 0:0012, Figure 5). When
the data for all four PVs were combined, post-
ablation PV and LA potentials were signiﬁcantly
smaller than pre-ablation (p < 0:0001, Figure 6).
Comparison of the early and later cases revealed that
the amplitude of remaining PV-LA potentials in the
later cases was signiﬁcantly smaller than in the early
cases (Figure 7).
3) Follow-up Results
During mean follow-up periods of 24:1 4:1 and
13:3 1:7 months, AF recurred in 38% (13/34
cases) and 13% (2/15 cases) in the early and later
cases, respectively (Table 4, Figure 8). Twelve of
the 13 and 2 of the 2 recurrence cases were from the
group of partial elimination. In the early cases, the
remaining 21 patients (62%) were free from AF
including 16 cases on drugs that were previously
ineﬀective and 5 cases not using drugs. In the later
cases, the remaining 13 patients (87%) were free
from AF including 2 cases on drugs and 11 cases oﬀ
drugs. Even in patients with AF recurrence, the
frequency and duration of AF episodes were mark-
edly decreased with medication which was previ-
ously ineﬀective. Anyhow the superior results in the
present study may due to a combination of drugs and
ablation.
Table 3 Ablation procedure in early vs. late cases.
LSPV
Early/Late
RSPV
Early/Late
LIPV
/Late
RIPV
/Late
Total ABL Time (min) 7:4 4:3 (3–18)/14:8 7:8 (2–34) 4:9 2:4 (2–12)/10:7 5:6 (2–26) /9:9 4:3 (3.5–20) /11:9 4:6 (6.5–21)
No. of RF delivery 2:2 1:1 (1–4)/3:5 1:5 (1–6) 1:5 0:7 (1–3)/2:5 1:2 (1–6) /2:4 1:0 (1–4) /2:6 0:7 (2–4)
# Fisher’s exact test
POST
0.25±0.40
PRE
1.34±0.34
POST
0.26±0.21
PRE
1.17±0.29
POST
0.64±0.68
PRE
2.68±1.16
POST
0.57±0.54
PRE
2.09±0.80
P<0.0001
P<0.0001P<0.0001
P=0.0012
mVmV
mV mV
LSPV (n=47)
LIPV (n=14)RIPV (n=7)
RSPV (n=47)
6
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4
3
2
1
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Figure 5 Comparison of LA-PV junctional potentials between pre- and post-PV ablation.
After PV ablation, amplitudes of all PV potentials were signiﬁcantly decreased as compared to pre-ablation (LSPV: p < 0:001,
RSPV: p < 0:0001, LIPV: p < 0:0001, RIPV: p ¼ 0:0012).
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Table 4 The results post ablation and follow up data.
Early cases, N ¼ 34
(2 PVs each, total 68 PVs)
Later cases, N ¼ 15
(3–4 PVs, total 53 PVs)
Complete elimination
(PV)
23=68 ¼ 33:8%
(12/34 LSPV, 11/34 RSPV)
44=53 ¼ 83%
(13/15 LSPV, 12/15 RSPV, 13/15 LIPV, 6/8 RIPV)
(Annihilation)
Partial elimination (PV) 38=68 ¼ 55:9% (20/34 LSPV, 18/34 RSPV) 4=53 ¼ 7:55% (1/15 LSPV, 1/15 RSPV, 1/15 LIPV, 1/8 RIPV)
PV-LA dissociation (PV) 5=68 ¼ 7:4% (2/34 LSPV, 3/34 RSPV) 1=53 ¼ 1:9% (1/15 RSPV)
AFL (PV) 2=68 ¼ 2:9% (1/34 LSPV, 1/34 RSPV) 4=53 ¼ 7:55% (1/15 LSPV, 1/15 RSPV, 1/15 LIPV, 1/8 RIPV)
Amplitude of remaining
potentials
PV (mV) 1:18 0:92 0:55 0:45
LA (mV) 0:23 0:12 0:14 0:10
Recurrence 38.2% (13/34) 13.3% (2/15)
Total procedure time
(min)
135 30 (98–190) 272 74 (180–420)
Total ﬂuoroscopic time
(min)
40 10 (28–59) 77 22 (34–110)
Follow up period (M) 24:1 4:1 13:3 1:7
mV LSPV
4
3
2
1
0
P=0.024
0.79±0.74 0.29±0.36
Early Cases
(n=32)
Later Cases
(n=14)
mV RSPV
2.25
1.75
1.25
0.75
0.25
P=0.008
0.71±0.54 0.29±0.39
Early Cases
(n=32)
Later Cases
(n=14)
Figure 7 PV potentials just after PV ablation.
PV potentials just after PV ablation in the later cases were signiﬁcantly lower than those in the early cases (RSPV: p ¼ 0:008,
LSPV: p < 0:024), meaning that we were able to more thoroughly ablate than in the early study. As a result, we obtained more
complete elimination (annihilation) in the later cases (83%) than in the early cases (34%). (See Table 4).
Figure 6 Comparison of LA-PV junctional
potentials between pre- and post-PV ablation.
All post-ablation PV and LA potentials
around PV ostium were signiﬁcantly decreas-
ed as compared to those of pre ablation (Post
ABL PV: p < 0:0001, Post ABL LA:
p < 0:0001) versus Pre ABL JP, respectively.
ABL: ablation, JP: junctional potentials, PV:
pulmonary vein, LA: left atrium.
N=47
P<0.0001 P<0.0001
1.66±0.55 0.25±0.35 0.13±0.14
Pre ABL JP Post ABL PV Post ABL LA
0
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In all 49 patients, 3-dimensional CT was per-
formed one, three months and six months after the
procedure. No evidence of severe PV stenosis was
found except for six cases, showing slight shrinkage
of the PV ostium in three, mild PV stenosis with 30–
50% narrowing in two and 50–60% narrowing in one
in a manner consistent with late progression of
inferior PV. However, no symptoms were noted in
P<0.0001
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1.15±0.45 0.10±0.15
Recurrence
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Figure 9 Comparison of post PV ablation LA-PV junctional potentials between recurrence and non-recurrence group.
The remaining PV potentials in 32 non-recurrence cases (except for 2 cases developing AFL) were deﬁnitely smaller (p < 0:0001)
than those in 15 recurrence cases.
Figure 8 Kaplan–Meier curves for AF free
ratio post PV ablation in early and later cases.
Although it was not a signiﬁcant diﬀerence
between the two groups, in the later cases, 13
patients (87%) were free from AF. Even in
patients with AF recurrence, the frequency
and duration of AF episodes were markedly
decreased with the medication which had
been ineﬀective previously.
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these six cases.
4) Comparison of Remaining Potentials between
Recurrence and Non-recurrence Cases
When we compared the amplitude of remaining
potentials in PV and periostial regions between the
recurrence and non-recurrence groups, the remaining
PV potentials in 32 non-recurrence cases (except for
2 cases developing AFL) were deﬁnitely smaller
than those in 15 recurrence cases (p < 0:0001,
Figure 9). When a cut-oﬀ level of less than
0.4mV in receiver operating characteristic curves
was used, its negative predictive value for non-
recurrence of AF was 93% and speciﬁcity was 95%.
5) Complications
A transient ST segment elevation in inferior ECG
leads was noted in 3 patients, most likely as a result
of coronary air embolism during catheter exchange.
No cerebrovascular accidents were documented
during and after the procedure. No clot formation
in the catheter was noted. Three patients had minor
pericardial eﬀusion after ablation, with one of them
requiring a drain. Phrenic nerve paralysis has never
been observed following RSPV ablation.
6) Discussion
There have been several reports that electrical PV
isolation is a promising therapeutic approach against
paroxysmal AF caused by the presence of triggering
foci within the PVs.1–3) In some of the earlier studies,
however, the rate of AF recurrence was as high as
44%.2) Furthermore, it has been pointed out that
more proximal portions of the PV-LA junction
appear to play an important role, since in 13% of
cases with AF recurrence, impulse formation origi-
nated more proximally than the ﬁrst target regions.2)
Based on those considerations, complete PV isola-
tion as a purely anatomical approach has recently
been advocated.11,12) On the other hand, Oral et al.
reported that after a complete PV isolation, AF
persisted in 40% of cases.13) They pointed out the
possibility that, in addition to the presence of
triggering foci in the PVs, many other factors could
contribute to the maintenance of AF.13) It appears
especially important to modify the arrhythmogenic
substrate in the posterior LA region including the PV
ostia, since the Maze operation,14) surgical PV
isolation,7) radial approach,8) or radio-frequency
ablation during open-heart surgery15) often produced
excellent clinical results.
In this regard, it is likely that the myocardial
sleeve of the LA entering into the PVs is thicker at
the PV-LA junction, often showing abrupt change in
direction.17) Furthermore, it tends to be more
prominent in the superior PVs,18) and node-like cells
with automaticity may also be found around the PV
ostium.19) However, Saliba et al. reported that it was
diﬃcult to obtain eﬀective compression of a balloon
against the PV ostia with suﬃcient coaxiality due to
the discordant diameters of balloon and PV ostia.20)
In our novel RF balloon catheter system, those
problems were solved by adopting a funnel-shaped
balloon in diﬀerent sizes and having suﬃcient
ﬂexibility as well as compliance. As a result, our
earlier animal experiments using porcine hearts have
shown that this catheter could ablate not only the
PV-LA junction, but also the LA tissue around the
PV ostia in a manner similar to a surgical encircling
incision.9)
In our initial clinical studies on patients with
paroxysmal AF, we ablated only superior PVs.
However, fairly good results were obtained despite
a high ratio of partial elimination (55.9%).16) This
could probably be explained by the fact that a
majority of PV triggers are located in supeior PVs,3)
and the eﬀect of local denervation of the ganglionic
plexus around the supeior PV-LA junctions by the
ablation.31) Furthermore, as shown in Figure 4, even
some cases in the partial elimination group remained
in sinus rhythm after the procedure. Our question
then was to what extent we should ablate the PV-LA
junctional region to prevent the recurrence of AF.
Thus, in the later cases, we tried to deliver a grater
amount of RF energy to the ostial regions of all four
PVs so that possible triggering foci would be more
completely isolated. As a result, percentage of
annihilation was markedly increased, whereas cases
with AF recurrence were reduced as compared to the
early cases. Therefore, less procedure time may be
associated with higher recurrence of AF. One other
signiﬁcant ﬁnding obtained in the present study was
that when the amplitude of all the remaining PV-LA
potentials was decreased to less than 0.4mV, non-
recurrence of AF could be predicted with high
sensitivity and speciﬁcity.
7) Safety from Thromboembolism and PV Stenosis
Either continual suction of blood (early cases) or
infusion of 5% glucose solution through the central
lumen of the catheter (later cases) using a rotary
pump during energy delivery allowed us to avoid
overheating of PV blood and resultant thrombus
formation. Thus, no cases of overt thrombus for-
mation nor episodes of thromboembolism have been
observed. On the otherhand, development of PV
stenosis caused by overheating of PV wall has been
reported as a serious complication of the conven-
tional PV ablation method.4,5) Delivery of lower
energy to avoid such overheating could, however,
result in an insuﬃcient ablation. In the present study,
no signiﬁcant PV stenosis was noted even after
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suﬃcient energy deliveries except for ﬁve cases
having a slight distortion of the PV-LA junction and
one case having a mild (50–60%) stenosis in 3-
dimensional CT. In this regard, it has been reported
that PV stenosis was rare when lesions were made
more proximal to the ostium.11) The present balloon
circumferentially ablating the ostial regions probably
avoided PV stenosis in the same manner. It should
also be pointed out that the temperature measured at
the conventional catheter tip in contact with the
endovascular surface may underestimate deeper
tissue temperature since the tip is being convectively
cooled by the blood ﬂow,21) and this may explain the
development of PV stenosis at an apparently low
temperature in conventional studies. According to a
more recent paper, acute heat-induced contraction of
PVs was observed at a distal ablation catheter
temperature of 60–65 C. Furthermore, our patient
who developed mild stenosis had a relatively small
(13mm) diameter of the inferior PV and ablation
was carried out slightly deeper into the PV. There-
fore, we should pay special attention to the temper-
ature and catheter position during PV ablation.
Fortunately, in the present study, temperature of
the tissue in contact with the balloon during ablation
was shown to be always lower than that of the
balloon membrane (50–65 C) according to the
repeated in vitro and animal experiments. The
present method would thus be superior as long as
ablation of more proximal regions of the PV-LA
junction is achieved with suﬃcient energy delivery.
8) Withdrawal of Drugs
Needless to say, withdrawal of drugs soon after
the procedure would be most advantageous to any
patient. However, it has been observed that, during
long-term follow-up, some patients with recurrence
of AF (especially several weeks after the PV
isolation) became responsive to the drug that were
previously ineﬀective. This ﬁnding may be ex-
plained either by inﬂammatory changes due to RF
energy or by a delayed therapeutic eﬀect.23) There-
fore, we attempt to withdraw drugs carefully to give
the patient a better quality of life.
9) Future Perspectives
Several reports have pointed out that the posterior
wall of LA near the PV ostia and the left atrial
appendage would play an important role in main-
taining AF even in patients with chronic AF, since
the highest dominant frequency was localized in
those areas.24–26) Gerstenfeld et al. empirically
demonstrated proximal isolation of all PVs to reduce
future recurrence.27) Contrariwise, a more recent
report indicates that PV isolation may not be a
crucial method to maintain sinus rhythm, whereas
modiﬁcation of the posterior LA including the PV
ostia could be more important28) to treat AF. Based
on these diverse observations, combination of com-
plete PV isolation and modiﬁcation of the arrhyth-
mogenic substrate in the posterior LA wall around
the PV ostia may well be indicated to achieve better
results. It is hoped that our present approach could
fulﬁll these requirements.
10) Study Limitations
The number of patients as well as ablated PVs
might be too small to fully evaluate the eﬃcacy of
this treatment using the RBC system. Since the
follow-up period was too short particularly in later
cases, it could not be concluded that PV stenosis
would not occur. To date, however, no severe PV
stenosis with symptoms has been documented. Since
we did not carry out electrophysiological restudy of
all cases with AF recurrence, it cannot be determined
whether it relapsed from the ablated region or from
certain new foci in the LA, SVC, Marshall vein, and
so forth. Furthermore, we could not be certain that
the patients without recurrence did not receive
higher voltage at follow-up. However, there are
many ethical issues, at least in Japan, in putting
innocent patients who have regained their sinus
rhythm at potential risk by performing electrophy-
siological studies. It must also be pointed out that,
although a basket catheter is one of the most widely
accepted devices to record PV potentials,24,29) the
recorded potentials may not always represent direct
potentials of LA, but may reﬂect some far-ﬁeld
potentials, such as possible non-recurrence cases
with remaining potentials actually recording some
far-ﬁeld potentials such as that of the left atrial
appendage or HRA.
Hence, further improvement of the basket catheter
or the development of a new device for recording
direct LA potentials around the PV ostium may be
necessary to conﬁrm the range of ablation. It is
diﬃcult to conclude that our RBC system could
completely eradicate the AF, since the occurrence of
short periods of non-symptomatic AF was not ruled
out. Therefore, we should continue the anti-coagu-
lation therapy carefully at least for one year after the
procedure in view of the results in the AFFIRM
study.30) A multi-center clinical trial is now in
progress to more precisely evaluate the eﬃcacy of
this catheter system.
Conclusions
It is concluded that this novel balloon catheter
could ablate not only the PV-LA junction, but also
adjacent LA tissues around the PV ostia circum-
ferentially without the risk of PV stenosis or
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thromboembolism. The rate of AF recurrence was
extremely low, when both the superior and inferior
PVs were isolated and a marked decrease in the
amplitude of LA-PV potentials to less than 0.4mV
was obtained. Finally, we would like to emphasize
that circumferential ablation around the PV ostium
using this RBC system could achieve the equivalent
therapeutic eﬀect to that of conventional ablation,
even in a single session.
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